May & Baker Nigeria Plc (MAYBAK.ng) 2022 Annual Report

May & Baker Nigeria Plc (MAYBAK.ng) listed on the Nigerian Stock Exchange under the Pharmaceuticals sector has released it’s 2022 annual report.

For more information about May & Baker Nigeria Plc (MAYBAK.ng) reports, abridged reports, interim earnings results and earnings presentations visit the May & Baker Nigeria Plc (MAYBAK.ng) company page on AfricanFinancials.

Indicative Share Trading Liquidity

The total indicative share trading liquidity for May & Baker Nigeria Plc (MAYBAK.ng) in the past 12 months, as of 2nd March 2023, is US$870.51K (NGN379.73M). An average of US$72.54K (NGN31.64M) per month.

May & Baker Nigeria Plc 2022 annual report

Company Profile

May & Baker Nigeria Plc is one of Nigeria’s leading pharmaceutical companies. Founded in 1944, the firm has seen incredible growth over the years and is now listed on the Nigerian Stock Exchange. With over 1,000 staff members and numerous branches throughout the country, May & Baker provides quality, comprehensive healthcare solutions for the Nigerian population. The company’s focus on research and development has enabled them to develop and launch innovative products, helping to improve the health of the nation. The company has also been recognized for its commitment to corporate social responsibility, with the firm taking active steps to improve the quality of life of their employees, as well as of the local communities in which they operate. As May & Baker continues to grow, it is evident that the firm will remain a leader in Nigeria’s healthcare landscape.